Detalhe da pesquisa
1.
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER).
J Antimicrob Chemother
; 77(3): 758-766, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34849957
2.
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial.
J Antimicrob Chemother
; 75(11): 3373-3378, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32812025
3.
Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical Trial.
Iran J Pharm Res
; 20(4): 278-288, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35194446